Drug profile · INN
semuloparin sodium
MULSEVO
semuloparin sodium (MULSEVO) is a antithrombin-iii inhibitor.
EMA: application withdrawn
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — semuloparin sodium
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
semuloparin sodium (MULSEVO) is a antithrombin-iii inhibitor.
Key facts
INN semuloparin sodium
Brand MULSEVO
Mechanism Antithrombin-III inhibitor
Target Antithrombin-III
Mechanism of action
Antithrombin-III inhibitor
Primary target: Antithrombin-III
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is semuloparin sodium?
semuloparin sodium (MULSEVO) is a antithrombin-iii inhibitor.
What is the brand name for semuloparin sodium?
MULSEVO is a marketed brand name for semuloparin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.